Bilberry fruit extract
CAS 84082-34-8
Bilberry fruit extract (CAS 84082-34-8) is a pharmaceutical compound with 0 bioactivity targets and 6 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Bilberry fruit extract is linked to DTXSID9030836 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bilberry fruit extract used for in pharmaceutical contexts?
Bilberry fruit extract (CAS 84082-34-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bilberry fruit extract?
Bilberry fruit extract has 6 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Blood glucose increased, Drug ineffective, Dyspepsia, Oropharyngeal pain, Renal impairment. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bilberry fruit extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Blueberry Fruit Extract with EU status "permitted".
What clinical phase is Bilberry fruit extract in?
No phase 1-4 clinical development badge is rendered for Bilberry fruit extract because the matched compound identifier rows do not contain a max-phase value.